| Pfizer AG - Comirnaty LP.8.1 30 Mikrogramm, Injektionsdispersion in einer Fertigspritze | | 70403 | | 01 | | Comirnaty LP.8.1 30 Mikrogramm | | Injektionsdispersion in einer Fertigspritze | | J07BN01 | | Covid-19, Rna-Based Vaccine | | 06.08.2025 | | |
| | Composition | | Suspension: COVID-19 mRNA LP.8.1 30 µg pro dosi, ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diylis)bis(2-hexyldecanoas), 2-(polyethylenglycoli 2000)-N,N-ditetradecylacetamidum, 1,2-distearoyl-sn-glycero-3-phosphocholinum, cholesterolum, saccharum, trometamolum, trometamoli hydrochloridum, aqua ad iniectabile, 1 ml corresp.. | | Packungsbestandteile | | | |
|
